HighTower Advisors LLC raised its stake in Envision Healthcare Corporation (NYSE:EVHC) by 5.6% during the first quarter, according to its most recent disclosure with the SEC. The fund owned 4,541 shares of the company’s stock after buying an additional 240 shares during the period. HighTower Advisors LLC’s holdings in Envision Healthcare Corporation were worth $274,000 as of its most recent SEC filing.
Other hedge funds have also modified their holdings of the company. Livforsakringsbolaget Skandia Omsesidigt acquired a new stake in shares of Envision Healthcare Corporation during the first quarter valued at approximately $135,000. Korea Investment CORP purchased a new stake in shares of Envision Healthcare Corporation during the first quarter valued at about $141,000. Ameritas Investment Partners Inc. purchased a new stake in shares of Envision Healthcare Corporation during the first quarter valued at about $172,000. First Interstate Bank purchased a new stake in shares of Envision Healthcare Corporation during the first quarter valued at about $184,000. Finally, Daiwa Securities Group Inc. raised its stake in shares of Envision Healthcare Corporation by 60.9% in the first quarter. Daiwa Securities Group Inc. now owns 3,169 shares of the company’s stock valued at $194,000 after buying an additional 1,200 shares in the last quarter. 64.75% of the stock is owned by institutional investors and hedge funds.
Envision Healthcare Corporation (NYSE EVHC) opened at 55.99 on Monday. The company’s market capitalization is $6.50 billion. Envision Healthcare Corporation has a 12-month low of $53.12 and a 12-month high of $75.67. The firm’s 50-day moving average price is $60.20 and its 200 day moving average price is $61.95.
Envision Healthcare Corporation (NYSE:EVHC) last posted its quarterly earnings data on Tuesday, May 2nd. The company reported $0.69 EPS for the quarter, hitting the Zacks’ consensus estimate of $0.69. Envision Healthcare Corporation had a negative net margin of 9.16% and a positive return on equity of 5.75%. The company had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $2.52 billion. On average, equities research analysts expect that Envision Healthcare Corporation will post $1.40 EPS for the current fiscal year.
COPYRIGHT VIOLATION NOTICE: This news story was originally reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are accessing this news story on another domain, it was stolen and republished in violation of US and international trademark & copyright law. The original version of this news story can be accessed at https://stocknewstimes.com/2017/07/31/envision-healthcare-corporation-evhc-shares-bought-by-hightower-advisors-llc-updated.html.
Several brokerages recently issued reports on EVHC. Mizuho cut their price objective on Envision Healthcare Corporation from $70.00 to $60.00 and set a “neutral” rating for the company in a report on Tuesday, May 30th. Cantor Fitzgerald reiterated a “buy” rating and set a $80.00 price objective on shares of Envision Healthcare Corporation in a report on Tuesday, July 4th. Zacks Investment Research upgraded Envision Healthcare Corporation from a “sell” rating to a “hold” rating in a report on Tuesday, May 2nd. Jefferies Group LLC set a $75.00 price objective on Envision Healthcare Corporation and gave the stock a “buy” rating in a report on Friday, April 21st. Finally, Royal Bank Of Canada reiterated a “buy” rating and set a $72.00 price objective on shares of Envision Healthcare Corporation in a report on Wednesday, May 3rd. Three investment analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average target price of $71.89.
In other news, insider Robert Jon Coward sold 1,500 shares of the stock in a transaction dated Thursday, June 22nd. The shares were sold at an average price of $60.00, for a total transaction of $90,000.00. Following the completion of the transaction, the insider now directly owns 99,363 shares in the company, valued at approximately $5,961,780. The transaction was disclosed in a document filed with the SEC, which is available at this link. Over the last 90 days, insiders have sold 4,500 shares of company stock valued at $274,830. Company insiders own 3.10% of the company’s stock.
About Envision Healthcare Corporation
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
Receive News & Ratings for Envision Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Corporation and related companies with MarketBeat.com's FREE daily email newsletter.
